10x Genomics, Inc. Revenue Breakdown
No Revenue Breakdown for TXG on this site yet.
- 2025-12-31: Others Not split by product in the filing$642.82M100.00%; Total revenue $642.82M.
- 2024-12-31: Others Not split by product in the filing$610.78M100.00%; Total revenue $610.78M.
- 2023-12-31: Others Not split by product in the filing$618.73M100.00%; Total revenue $618.73M.
- 2022-12-31: Others Not split by product in the filing$516.41M100.00%; Total revenue $516.41M.
Source checked: the stored Revenue Breakdown page for TXG.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $642.82M 100.00% | $642.82M |
| 2024-12-31 | Not split by product in the filing $610.78M 100.00% | $610.78M |
| 2023-12-31 | Not split by product in the filing $618.73M 100.00% | $618.73M |
| 2022-12-31 | Not split by product in the filing $516.41M 100.00% | $516.41M |
| 2021-12-31 | Not split by product in the filing $490.49M 100.00% | $490.49M |
| 2020-12-31 | Not split by product in the filing $298.85M 100.00% | $298.85M |
| 2019-12-31 | Not split by product in the filing $245.89M 100.00% | $245.89M |
| 2018-12-31 | Not split by product in the filing $146.31M 100.00% | $146.31M |
| 2017-12-31 | Not split by product in the filing $71.08M 100.00% | $71.08M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $151.04M 100.00% | $151.04M |
| 2026-03-31 | Not split by product $150.84M 100.00% | $150.84M |
| 2025-12-31 | Not split by product $166.03M 100.00% | $166.03M |
| 2025-09-30 | Not split by product $149.00M 100.00% | $149.00M |
| 2025-06-30 | Not split by product $172.91M 100.00% | $172.91M |
| 2025-03-31 | Not split by product $154.88M 100.00% | $154.88M |
| 2024-12-31 | Not split by product $165.02M 100.00% | $165.02M |
| 2024-09-30 | Not split by product $151.65M 100.00% | $151.65M |
| 2024-06-30 | Not split by product $153.10M 100.00% | $153.10M |
| 2024-03-31 | Not split by product $141.01M 100.00% | $141.01M |
| 2023-12-31 | Not split by product $183.98M 100.00% | $183.98M |
| 2023-09-30 | Not split by product $153.64M 100.00% | $153.64M |
| 2023-06-30 | Not split by product $146.82M 100.00% | $146.82M |
| 2023-03-31 | Not split by product $134.28M 100.00% | $134.28M |
| 2022-12-31 | Not split by product $156.23M 100.00% | $156.23M |
| 2022-09-30 | Not split by product $131.07M 100.00% | $131.07M |
| 2022-06-30 | Not split by product $114.61M 100.00% | $114.61M |
| 2022-03-31 | Not split by product $114.50M 100.00% | $114.50M |
| 2021-12-31 | Not split by product $143.53M 100.00% | $143.53M |
| 2021-09-30 | Not split by product $125.30M 100.00% | $125.30M |
| 2021-06-30 | Not split by product $115.84M 100.00% | $115.84M |
| 2021-03-31 | Not split by product $105.82M 100.00% | $105.82M |
| 2020-12-31 | Not split by product $112.22M 100.00% | $112.22M |
| 2020-09-30 | Not split by product $71.82M 100.00% | $71.82M |
| 2020-06-30 | Not split by product $42.91M 100.00% | $42.91M |
| 2020-03-31 | Not split by product $71.91M 100.00% | $71.91M |
| 2019-12-31 | Not split by product $75.29M 100.00% | $75.29M |
| 2019-09-30 | Not split by product $61.21M 100.00% | $61.21M |
| 2019-06-30 | Not split by product $55.82M 100.00% | $55.82M |
| 2019-03-31 | Not split by product $53.58M 100.00% | $53.58M |
| 2018-12-31 | Not split by product $50.55M 100.00% | $50.55M |
| 2018-09-30 | Not split by product $36.61M 100.00% | $36.61M |
| 2018-06-30 | Not split by product $31.74M 100.00% | $31.74M |
| 2018-03-31 | Not split by product $27.41M 100.00% | $27.41M |